Search Results - "Holtegaard, Leonard M"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma by McWilliams, Robert R., Petersen, Gloria M., Rabe, Kari G., Holtegaard, Leonard M., Lynch, Pamela J., Bishop, Michele D., Highsmith, W. Edward

    Published in Cancer (01-01-2010)
    “…BACKGROUND: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are common in white persons and are associated with pancreatic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mutation Scanning of the RET Protooncogene Using High-Resolution Melting Analysis by Margraf, Rebecca L, Mao, Rong, Highsmith, W. Edward, Holtegaard, Leonard M, Wittwer, Carl T

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2006)
    “…Single-base pair missense mutations in exons 10, 11, 13, 14, 15, and 16 of the RET protooncogene are associated with the autosomal dominant multiple endocrine…”
    Get full text
    Journal Article
  5. 5

    RET Proto-Oncogene Genotyping Using Unlabeled Probes, the Masking Technique, and Amplicon High-Resolution Melting Analysis by Margraf, Rebecca L, Mao, Rong, Highsmith, W. Edward, Holtegaard, Leonard M, Wittwer, Carl T

    Published in The Journal of molecular diagnostics : JMD (01-04-2007)
    “…Single bp mutations in the RET proto-oncogene can cause multiple endocrine neoplasia type 2 syndromes. The conventional approach for genotyping RET mutations…”
    Get full text
    Journal Article
  6. 6

    Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing by Pratt, Victoria M, Caggana, Michele, Bridges, Christina, Buller, Arlene M, DiAntonio, Lisa, Highsmith, W. Edward, Holtegaard, Leonard M, Muralidharan, Kasinathan, Rohlfs, Elizabeth M, Tarleton, Jack, Toji, Lorraine, Barker, Shannon D, Kalman, Lisa V

    Published in The Journal of molecular diagnostics : JMD (01-05-2009)
    “…The number of different laboratories that perform genetic testing for cystic fibrosis is increasing. However, there are a limited number of quality control and…”
    Get full text
    Journal Article